共 40 条
[1]
Bl S., Nilsson T.K., Ranby M., Hallmans C., Hellsten C., Fibrinolytic variables are related to age, sex, blood pressure and body build measurements: A cross-sectional study in Norsjö, Sweden, J Clin Epidemiol, 42, pp. 719-723, (1989)
[2]
Jansson J.H., Johansson B., Boman K., Nilsson T.K., Hypofibrinolysis in patients with hypertension and elevated Cholesterol, J Intern Med, 229, pp. 309-316, (1991)
[3]
Landin K., Tengborn I., Smith U., Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease, J Intern Med, 227, pp. 273-278, (1990)
[4]
Chmielewska J., Wiman B., Determination of tissue plasminogen activator and its fast inhibitor in plasma, Clin Chem, 32, pp. 482-485, (1986)
[5]
Dawson S., Henney A., The Status of PAI-1 as a risk factor for arterial and thrombotic disease: A review, Atherosclerosis, 95, pp. 105-117, (1992)
[6]
Hamsten A., de Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., Et al., Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction, Lancet, 2, pp. 3-9, (1987)
[7]
Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/Intemational Society of Hypertension meeting, Jhypertens, 11, pp. 905-918, (1993)
[8]
de Fronzo R.A., Ferrannini E., Insulin resistance: A multifaceted syndrome responsible for NID DM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, pp. 173-194, (1991)
[9]
Daly P.A., Landsberg L., Hypertension in obesity and NIDDM, Diabetes Care, 14, pp. 240-248, (1991)
[10]
Seidell J.C., Cigolini M., Deslypere J.P., Charzewska J., Ellsinger B.M., Cruz A., Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men. The European Fat Distribution Study, Atherosclerosis, 86, pp. 251-260, (1991)